← Leaderboards
Fang-Chi Hsu
University Of Virginia
$846,291
Attributed
$2,538,874
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,538,874 · 2
By mechanism
U01$1,306,144 · 1
R01$1,232,730 · 1
Top collaborators
- Nicholette D. Allred2 shared
- Michael Patrick Bancks2 shared
- Keith L Keene2 shared
- Bradford B Worrall2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Li Li$10,636,659
- Song Hu$8,846,003
- Bradford B Worrall$7,974,253
Others in their field
Other Rising Stars on “Disease Outcome”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Suma Babu · Massachusetts General Hospital$34,837,233
- Sabrina Paganoni · Massachusetts General Hospital$34,837,233
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jinsy Andrews · Columbia University Health Sciences$21,294,649
Research focus
Disease OutcomeAdultSocial Health DeterminantsEthnic PopulationGeneticClinical RiskCohortEtiologyMulti-EthnicTraitPhenotypeGenotypeSocial DeterminantsAmericanBiochemical MarkersBiochemicalAfrican AncestryBeta CellBehavioralAdverse OutcomeAccelerated Epigenetic AgingCardiovascular Disorder RiskCaringBuilt Environment
Grant awards (4)
Metabolomic and genomic expansion of type 2 diabetes subtyping in multiethnic populations$663,086
U01 · FY2025 · DK
Shared and novel contributors to risk of stroke and stroke recurrence in a multiethnic population â the role of social determinants of health, genetics, and epigenetics$565,495
R01 · FY2025 · NS
Shared and novel contributors to risk of stroke and stroke recurrence in a multiethnic population â the role of social determinants of health, genetics, and epigenetics$667,235
R01 · FY2024 · NS
Metabolomic and genomic expansion of type 2 diabetes subtyping in multiethnic populations$643,058
U01 · FY2024 · DK